D
Esperion Therapeutics, Inc. ESPR
$1.50 $0.000.00%
Recommendation
Prev Close
Volume
Avg Vol (90D)
Market Cap
Dividend & Yield
--
52-Week Range
P/E (TTM)
--
EPS (TTM)

12/31/2024 09/30/2024 06/30/2024 03/31/2024 12/31/2023
Revenue 332.31M 295.45M 277.79M 229.74M 116.33M
Total Other Revenue -- -- -- -- --
Total Revenue 332.31M 295.45M 277.79M 229.74M 116.33M
Cost of Revenue 114.84M 107.43M 108.00M 109.82M 129.37M
Gross Profit 217.48M 188.03M 169.78M 119.92M -13.04M
SG&A Expenses 163.07M 171.57M 164.84M 154.61M 142.52M
Depreciation & Amortization -- -- -- -- --
Other Operating Expenses -- -- -- -- --
Total Operating Expenses 277.91M 279.00M 272.84M 264.43M 271.90M
Operating Income 54.40M 16.46M 4.95M -34.69M -155.56M
Income Before Tax -51.75M -86.77M -98.50M -86.51M -209.25M
Income Tax Expenses -- -- -- -- --
Earnings from Continuing Operations -51.75 -86.77 -98.50 -86.51 -209.25
Earnings from Discontinued Operations -- -- -- -- --
Extraordinary Item & Accounting Change -- -- -- -- --
Minority Interest in Earnings -- -- -- -- --
Net Income -51.75M -86.77M -98.50M -86.51M -209.25M
EBIT 54.40M 16.46M 4.95M -34.69M -155.56M
EBITDA 54.50M 16.53M 5.03M -34.57M -155.40M
EPS Basic -0.23 -0.62 -0.84 -0.97 -2.11
Normalized Basic EPS 0.04 -0.21 -0.35 -0.60 -1.32
EPS Diluted -0.25 -0.65 -0.86 -0.99 -2.12
Normalized Diluted EPS 0.01 -0.24 -0.37 -0.63 -1.32
Average Basic Shares Outstanding 748.55M 665.39M 582.33M 502.78M 411.96M
Average Diluted Shares Outstanding 768.93M 685.77M 602.71M 523.16M 411.96M
Dividend Per Share -- -- -- -- --
Payout Ratio -- -- -- -- --
Weiss Ratings